Oral therapy with flurithromycin in ear, nose and throat infections

G B Galioto1, D Passali, G B Catalano

  • 1Otorhinolaryngologic Department, Policlinico S. Matteo, University of Pavia, Italy.

Insights

Flurithromycin ethylsuccinate (FE) demonstrated high efficacy and excellent tolerability in treating ear, nose, and throat infections. This antibiotic achieved significant clinical recovery and pathogen eradication in most patients, proving its safety and effectiveness.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Pharmacology

Background:

  • Ear, nose, and throat (ENT) infections encompass a range of acute and chronic inflammatory conditions.
  • Antibiotic therapy is a cornerstone in managing bacterial ENT infections.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of flurithromycin ethylsuccinate (FE) in patients with ENT infections.
  • To assess clinical recovery rates, pathogen eradication, and adverse events associated with FE treatment.

Main Methods:

  • A clinical study involving 103 patients with various ENT infections (pharyngitis/tonsillitis, rhinosinusitis, otitis, sialadenitis).
  • Patients received flurithromycin ethylsuccinate (FE) 375 mg every 12 hours for an average of 8.2 days.
  • Clinical efficacy was assessed in 101 patients, and bacteriological evaluation was performed in 95 patients.

Main Results:

  • Complete clinical recovery was observed in 88.2% of patients, with improvement in 9.9%.
  • Bacteriological pathogen eradication was achieved in 94.7% of evaluable patients.
  • Tolerability was rated as excellent in 81.6% and good in 15.5% of cases.

Conclusions:

  • Flurithromycin ethylsuccinate (FE) is a safe and effective antibiotic for treating acute and chronic ENT infections.
  • The high rates of clinical efficacy, pathogen eradication, and excellent tolerability support the use of FE in otolaryngology practice.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...